Design, Synthesis, and Pharmacology of a Highly Subtype-Selective GluR1/2 Agonist, (<i>RS</i>)-2-Amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic Acid (Cl-HIBO)Esben Jannik Bjerrum, Ulf Madsen, Anders S. Kristensen et al.|Journal of Medicinal Chemistry|2003Cited by 43
Crystal Structure and Pharmacological Characterization of a Novel N-Methyl-d-aspartate (NMDA) Receptor Antagonist at the GluN1 Glycine Binding SiteTrine Kvist, Hans Bräuner‐Osborne, Fatemeh Mehrzad Tabrizi et al.|Journal of Biological Chemistry|2013Cited by 31
The Glutamate Receptor GluR5 Agonist (<i>S</i>)-2-Amino-3-(3-hydroxy-7,8-dihydro-6<i>H</i>-cyclohepta[<i>d</i>]isoxazol-4-yl)propionic Acid and the 8-Methyl Analogue: Synthesis, Molecular Pharmacology, and Biostructural Characterization†PDB ID: 2WKY.Rasmus P. Clausen, J.S. Kastrup, Peter Naur et al.|Journal of Medicinal Chemistry|2009Cited by 20
4-Alkylated homoibotenic acid (HIBO) analogues: Versatile pharmacological agents with diverse selectivity profiles towards metabotropic and ionotropic glutamate receptor subtypesUlf Madsen, Hans Bräuner‐Osborne, Darryl S. Pickering et al.|Neuropharmacology|2005Cited by 17
Synthesis and in vitro pharmacology at AMPA and kainate preferring glutamate receptors of 4-heteroarylmethylidene glutamate analoguesJon Valgeirsson, Ulf Madsen, Jeppe K. Christensen et al.|Bioorganic & Medicinal Chemistry|2003Cited by 11